Throughout the last 40 years, research efforts have been undertaken to elucidate the potential correlation between the changes in IgG glycosylation in IBD patients and other parameters of clinical importance, such as C-reactive protein (CRP) levels and disease activity, with ambiguous results [73,103,104,108]. This evidence concerns the gene CRP and inflammatory bowel disease.